Alpha Cognition Inc. (ACOG) - Latest Market Data

Track the most recent price, market cap, volume, and performance data for Alpha Cognition Inc. (ACOG).

Download StockRank on Google Play Download StockRank on the App Store

Equity Overview

Price & Market Data

Price: $9.13

Daily Change: -$0.22 / 2.41%

Daily Range: $8.96 - $9.45

Market Cap: $146,260,768

Daily Volume: 55,615

Performance Metrics

1 Week: 0.22%

1 Month: -15.46%

3 Months: 21.90%

6 Months: 52.17%

1 Year: -28.39%

YTD: 55.01%

Details

Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease. Its pre-clinical development programs comprise ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer's disease; ALPHA-1062 sublingual formulation for acute pancreatitis; ALPHA-1062 intranasal formulation for the treatment of cognitive impairment with mild traumatic brain injury; and ALPHA-0602, ALPHA-0702, and ALPHA-0802 programs for the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis disease and spinal muscular atrophy. The company was founded in 2000 and is headquartered in Vancouver, Canada.

Selected stocks

D/B/A Compass Diversified Holdings Shares of Beneficial Interest (CODI)

abrdn Life Sciences Investors Shares of Beneficial Interest (HQL)

Chicago Atlantic Real Estate Finance, Inc. (REFI)